71
Views
6
CrossRef citations to date
0
Altmetric
Articles

Oxidation of pharmaceutical compounds by ozonation and ozone/activated carbon coupling: a kinetic approach

, , &
Pages 18956-18963 | Received 26 Mar 2015, Accepted 05 Sep 2015, Published online: 25 Sep 2015
 

Abstract

The aim of this work was to study the efficiency of ozone (O3)/activated carbon (AC) coupling to remove metoprolol and fluoxetine. A kinetic study was performed at pH ranging from 3 to 9. Results were correctly modelled by a global first-order model (r2 > 0.99) and were compared to those obtained with the ozonation process. It was shown that O3/AC coupling was the most efficient process. At pH 9, the degradation kinetic constant reached 0.72 min−1 with O3/AC coupling while its maximum value was 0.34 min−1 with ozonation. In each experimental condition and for the two target compounds, this coupling allowed a fast and total pollutant removal. Moreover, its performances were not significantly influenced by the experimental conditions, contrary to the ozonation process which is strongly influenced by the pH and the nature of the pollutant. O3/AC coupling remained efficient even if the operational parameters disfavour pollutant oxidation.

Acknowledgements

The authors wish to thank Xavier Bourrain and the Agence de l’Eau Loire Bretagne for their technical and financial support, and Pica Jacobi for gratuitously supplying AC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.